moderate – Communicable Diseases Research

Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway

Article

Published on 2023-01-302022-11-16
Journal: Journal of ethnopharmacology
[Category] 신종인플루엔자, 치료기술,

SARS-CoV-2 removal by mix matrix membrane: A novel application of artificial neural network based simulation in MATLAB for evaluating wastewater reuse risks

Article

Published on 2023-01-012022-11-15
Journal: Chemosphere
[Category] COVID19(2023년), SARS, 치료기술, 치료제,

A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson

SARS-CoV-2 백신에 대한 포괄적인 검토: Pfizer, Moderna & Johnson & Johnson

Review

Published on 2022-12-312022-09-11
Journal: Human vaccines & immunotherapeutics
[Category] COVID19(2023년), SARS, 변종,

[키워드] Adenovirus administration age approval clinical clinical trial clinical trials coronavirus coronavirus. COVID-19 COVID-19 vaccine COVID-19 vaccines effective Efficacy General population group Johnson Johnson & Johnson Johnson & large cohort mechanism moderate Moderna mRNA vaccines Novel coronavirus ongoing trial ongoing trials outbreak pandemic participant Pfizer Safety SARS-CoV-2 SARS-CoV-2 coronavirus SARS-COV-2 infection shown Side effects Spike protein symptomatic SARS-CoV-2 infection tested the SARS-CoV-2 the spike protein the United State Trial United States Vaccinations Vaccine vaccine administration variant
[DOI] 10.1080/21645515.2021.2002083 PMC 바로가기 [Article Type] Review

Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic

Article

Published on 2022-12-202022-11-16
Journal: The Science of the total environment
[Category] COVID19(2023년), SARS, 변종,

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

Review Article

Published on 2022-12-172022-10-27
Journal: Brain Communications
[Category] COVID-19,

[키워드] 95% confidence interval Anxiety Anxiety Disorder calculated chronic COVID syndrome CINAHL Cognitive impairment conducted consequence control group control groups controls COVID-19 COVID-19 hospitalization COVID-19 infection curated database disorder duration of follow-up Evidence fatigue Follow-up Frequency help heterogeneity Hospitalization indicate Infection Insomnia linear Long COVID management mental health Meta-analysis moderate neurological Neuropsychiatric neuropsychiatry pandemic patients peer-reviewed study persistent post-acute sequelae of COVID-19 post-traumatic Prevalence prevalent Psychological PsycINFO reported symptom searched severity Sleep disturbance Stress Subgroup analysis survivor Symptom Symptoms systematic review unique was measured
[DOI] 10.1093/braincomms/fcab297 PMC 바로가기 [Article Type] Review Article

Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination

Article

Published on 2022-12-012022-11-15
Journal: Journal of medical virology
[Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] acute respiratory syndrome addition adenoviral-vectored vaccine antibody AZD1222 binding antibody BNT162b2 booster booster vaccination Booster vaccine comparable Complete coronavirus Coronavirus 2019 COVID-19 demonstrated develop dose Effect enrolled enzyme-linked immunosorbent Heterologous highest immune evasion immune response Immunogenicity analysis individual induce interferon-γ Messenger RNA Mild moderate mRNA mRNA vaccine mRNA-1273 mutations NAb titer NAbs neutralization neutralize Neutralizing Neutralizing activity neutralizing antibody observé Omicron variant Omicron. overcome participant raise receive receiving reduction response Serious Adverse Events significant increase Spike protein T-cell activation T-cell Response T-cell responses vaccination Vaccine waning immunity was recorded were measured
[DOI] 10.1002/jmv.28044 PMC 바로가기

Clinical course of novel COVID-19 infection in pregnant women

Observational Study

Published on 2022-12-012022-10-05
Journal: The journal of maternal-fetal & neonatal medicine
[Category] COVID19(2023년), SARS, 임상, 치료기술,

[키워드] alanine aminotransferase analyzed Anemia Anosmia antimicrobial APGAR score Asymptomatic C-reactive protein carbapenem change clinical Clinical course clinical symptom contribute coronavirus cough Course COVID-19 COVID-19 infection CPAP therapy creatinine CRP decrease demographic disease drug Elimination epidemiological erythrocyte excluded form Immunity increase in Infection interferon Laboratory lactate dehydrogenase LDH leukopenia low molecular weight lymphocyte manifestation maternal and perinatal outcomes. mechanical ventilation Mild moderate morbidity Neonatal Neonatal COVID-19 Neonate no evidence of occurred outcome outcomes Oxygenation PCR polymerase chain predictor Pregnancy pregnant women preterm delivery prospective observational study recommendations reported required SARS-CoV-2 Severe case severe COVID-19 Spontaneous Transmission virus women
[DOI] 10.1080/14767058.2020.1850683 PMC 바로가기 [Article Type] Observational Study

Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines

Article

Published on 2022-12-012022-11-15
Journal: Journal of medical virology
[Category] COVID19(2023년), SARS, 변종, 진단,

COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients

Article

Published on 2022-12-012022-11-15
Journal: Annals of Medicine
[Category] COVID19(2023년), SARS, 진단, 치료제,

[키워드] addition affecting alleviate antiviral medication antiviral medicine approved Baricitinib Care caused Clinical practice clinical recommendations Community courses COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment COVID-19 treatments Critical deaths develop disease disorder drug Dyspnea effective effective drugs European European Medicines Agency European Union Evidence guidelines. Health healthcare hospital Hospitalization Hospitalized hospitalized patient hypoxia Intervention involved life-threatening lung involvement management Mild moderate molnupiravir monoclonal antibodies monoclonal antibody Most patient Multiorgan dysfunction New outcome public health recommendation Remdesivir Respiratory failure rheumatoid arthritis SARS-CoV-2 Septic shock severe symptom Symptom the disease the patient therapy Thromboembolism Tocilizumab treat Treatment treatment strategy union vaccination
[DOI] 10.1080/07853890.2022.2133162 PMC 바로가기

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial

Article

Published on 2022-12-012022-10-06
Journal: The Lancet Regional Health - Western Pacific
[Category] 진단,

[키워드] acute respiratory syndrome Administered Adults adverse event AEs age analysis assessment assigned BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine China Chinese clinical trial Complete Completed conducted coronavirus COVID-19 development dose double-blind Efficacy and safety enrolled Follow-up geometric mean titer GMT GMTs Han Chinese healthy immune response immunogenicity immunogenicity endpoint Inc independent individual injection intramuscular Intramuscular injection investigators Laboratory parameters management messenger Messenger RNA Mild moderate mRNA vaccine Neutralising Antibodies neutralising antibody of BNT162b2 participant Participants pharmaceutical Placebo placebo-controlled trial randomisation randomised Randomly reactogenicity receive recipients recruited reduced remained reported resolved Result robust Safety SARS-CoV-2 SARS-CoV-2 variant SCR second dose sera serious AE seroconversion rate severity Shanghai Sponsor statisticians stratified T-cell Response the placebo group Tolerability Treatment Trial utilised vaccination vaccination. vaccine administration were blinded
[DOI] 10.1016/j.lanwpc.2022.100586 PMC 바로가기 [Article Type] Article